Drug Control Act; adds certain chemicals to Schedules I, II, IV, and V of Act.
Impact
The modifications introduced by HB1450 will considerably tighten the control over these newly scheduled substances, imposing stricter regulations on their manufacturing, distribution, and possession. By adding specific new chemicals that have been proven to have harmful effects or a high potential for abuse, the bill aims to enhance public health and safety by reducing the risk of these substances being misused. The bill aligns Virginia’s regulations with national trends and recommendations regarding the management of controlled substances in an effort to combat substance abuse effectively.
Summary
House Bill 1450 is an amendment to the Drug Control Act in Virginia aimed at addressing the growing concerns regarding certain synthetic and potentially dangerous drugs. This bill proposes adding new chemicals to Schedules I, II, IV, and V, which categorizes them as controlled substances and regulates their distribution and use. The addition of these substances to the schedule is intended to curb their availability and prevent abuse, especially in light of the ongoing opioid crisis affecting many communities across Virginia.
Contention
Notable points of contention surrounding HB1450 include potential concerns raised by advocacy groups about patients who legitimately need certain substances for medical reasons. Critics also argue that the inclusion of additional synthetic drugs could lead to criminalization of individuals who used these substances for recreational purposes without malicious intent. There is a call for a balanced approach that ensures illicit drugs are curtailed while not disproportionately affecting those with legitimate healthcare needs or shifting the focus solely onto criminalization rather than treatment options.
Adding and removing certain substances in schedules I, III and IV of the uniform controlled substances act and making conforming changes to the criminal code definition of fentanyl-related controlled substances.
A BILL for an Act to amend and reenact subsection 3 of section 19-03.1-05 of the North Dakota Century Code, relating to the scheduling of mitragynine as a schedule I controlled substance.